Results 21 to 30 of about 34,173 (255)

Epidemiology of Trypanosomiasis in Wildlife—Implications for Humans at the Wildlife Interface in Africa

open access: yesFrontiers in Veterinary Science, 2021
While both human and animal trypanosomiasis continue to present as major human and animal public health constraints globally, detailed analyses of trypanosome wildlife reservoir hosts remain sparse.
Dr. Keneth Iceland Kasozi   +19 more
semanticscholar   +1 more source

An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases

open access: yesMolecules, 2021
The protozoan diseases Human African Trypanosomiasis (HAT), Chagas disease (CD), and leishmaniases span worldwide and therefore their impact is a universal concern.
Violeta Kourbeli   +5 more
semanticscholar   +1 more source

Monitoring the elimination of human African trypanosomiasis at continental and country level: Update to 2018

open access: yesPLoS Neglected Tropical Diseases, 2020
Background In 2012 human African trypanosomiasis (HAT), also known as sleeping sickness, was targeted for elimination as a public health problem, set to be achieved by 2020.
J. Franco   +8 more
semanticscholar   +1 more source

New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story

open access: yesTropical Medicine and Infectious Disease, 2020
The twentieth century ended with human African trypanosomiasis (HAT) epidemics raging across many parts of Africa. Resistance to existing drugs was emerging, and many programs aiming to contain the disease had ground to a halt, given previous success ...
Emily A. Dickie   +7 more
semanticscholar   +1 more source

TRYPANOSOMIASIS

open access: yes, 2023
Trypanosomatidae ailesinden protozoonlarının neden olduğu Afrika (uyku hastalığı) ve Amerika (Chagas hastalığı) trypanosomiasis hastalıkları, sırasıyla Afrika ve Latin Amerika'nın bazı bölgelerinde endemik olarak görülmektedir.
YILDIRIM, Ahmet, AKSOY. Tülay
openaire   +2 more sources

Extravascular Dermal Trypanosomes in Suspected and Confirmed Cases of gambiense Human African Trypanosomiasis

open access: yesClinical Infectious Diseases, 2020
Background The diagnosis of gambiense human African trypanosomiasis (gHAT) typically involves 2 steps: a serological screen, followed by the detection of living trypanosome parasites in the blood or lymph node aspirate.
M. Camara   +16 more
semanticscholar   +1 more source

Trypanosomiasis

open access: yesBrain Pathology, 1997
African (sleeping sickness) and American (Chagas' disease) trypanosomiasis, caused by protozoa of the family Trypanosomatidae, are diseases that are endemic in parts of Africa and Latin America, respectively. Physicians in developed countries may occasionally see cases because of extensive travel and immigration from endemic countries.
L, Chimelli, F, Scaravilli
openaire   +3 more sources

Design of an Epitope-Based Vaccine Ensemble for Animal Trypanosomiasis by Computational Methods

open access: yesVaccines, 2020
African animal trypanosomiasis is caused by vector-transmitted parasites of the genus Trypanosoma. T. congolense and T. brucei brucei are predominant in Africa; T. evansi and T. vivax in America and Asia.
Lucas Michel-Todó   +5 more
semanticscholar   +1 more source

Insights into the Control and Management of Human and Bovine African Trypanosomiasis in Zambia between 2009 and 2019—A Review

open access: yesTropical Medicine and Infectious Disease, 2020
Tsetse transmitted trypanosomiasis is a fatal disease commonly known as Nagana in cattle and sleeping sickness in humans. The disease threatens food security and has severe economic impact in Africa including most parts of Zambia.
Gloria M. Mulenga   +5 more
semanticscholar   +1 more source

Congenital Trypanosomiasis [PDF]

open access: yesJournal of Tropical Pediatrics, 2004
The last successfully treated case of congenital trypanosomiasis in Zambia was in October 1978, with detailed analysis of immunoglobulins, illustrating the waning of blood and serum levels of IgA, IgG, and IgM during treatment, up to 99 days after treatment. Twenty-five years later, we report on a case of congenital trypanosomiasis.
Mary Shilalukey, Ngoma   +11 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy